Steve Alley – Biography

Last update: January 14, 2026

Executive profile

Steve was Executive Director, Oncology R&D at Pfizer, and Executive Director, Antibody-Drug Conjugates Oncology at Seagen. Steve Alley joined MBrace Therapeutics in 2024.

Steve Alley is currently

Chief Scientific Officer at MBrace Therapeutics - View - MBrace Therapeutics org chart



Create your alert
to follow the career of Steve Alley.

Education

Steve Alley has a PhD in Organic Chemistry from University of Washington and a Postdoctoral Fellow in Chemistry from Penn State University.

They have also studied at University of Washington :

Find more alumni from University of Washington


They have also studied at Penn State University :

Find more alumni from Penn State University

The colleagues of Steve Alley

Company Colleagues
Homonyms
Industry Colleagues
  • In the Biotechnology industry, Steve Alley has 35,765 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Steve Alley.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call MBrace Therapeutics at +1 442 ... and ask for Steve Alley.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.